Diversified Player, BPH Energy Prospers backed by Sound Management Team

BPH Energy Limited, a diversified player, is listed with the code “BPH” on the Australian stock exchange. Headquartered in Australia, BPH invests across various sectors with significant interests in Advent Energy Ltd (22.6 per cent), Molecular Discovery Systems (20 per cent), Patagonia Genetics Pty Ltd (10 per cent) and Cortical Dynamics Ltd (4.39 per cent).

The company’s activities are aimed at achieving long-term value creation, supported by the growth of its key investments. BPH is advancing rapidly with its growth-driven strategies in biotech, resources and medical cannabis domain.

A Quick Look at BPH’s Investments

Oil and Gas Sector

BPH holds a significant interest in Advent Energy Limited, an oil and gas exploration entity. Advent has accumulated numerous hydrocarbon permits, both onshore (EP386 and RL1 in Bonaparte Basin) and offshore (PEP11 in Sydney Basin), that carry near term production prospects with advanced infrastructure and exploration upside.

Biotechnology Sector

The company owns interests in Cortical Dynamics Ltd and Molecular Discovery Systems in the biotech sector.

Cortical is a medical device technology company that has created brain function monitor – Brain Anaesthesia Response Monitor (BARM), with the aim of better detecting the implications of anaesthetic agents on brain activity, thereby assisting anaesthetists in holding patients optimally anaesthetised.

Engaged in the validation of biomarkers and drug discovery, Molecular Discovery Systems intends to certify HLS5 tumour suppressor gene as a novel gene, mainly for liver cancer.

Medical Cannabis Sector

BPH has recently entered into the medical cannabis market by acquiring a 10 per cent interest in Patagonia Genetics Pty Ltd, with an option of securing 49 per cent stake via a terms sheet.

BPH’s Management Team

Marking considerable progress, BPH has expanded its presence in multiple industries backed by a strong, efficient and experienced management team. The company’s board primarily includes three highly-qualified Directors – Mr David Breeze, Mr Tony Huston and Mr Charles Maling.

David Breeze, Managing Director and Executive Chairman

Aged 66 years, Mr David Breeze is a specialist in Corporate Finance with considerable stock broking and capital markets experience. He has been a business consultant to Daiwa Securities and has held director and executive positions in the stock broking sector.

He has held company directorships in the following listed companies during the last three years:

  • Grandbridge Limited (ASX: GBA) – From December 1999 to present.
  • MEC Resources Limited (ASX: MMR) – From April 2005 to November 2016.

Mr Breeze holds Bachelor of Economics and an MBA degree, and is a Fellow of the FINSIA (Financial Services Institute of Australasia) and the Australian Institute of Company Directors. He has acted as an Independent Expert under the Corporations Act and has published in the JASSA (Journal of the Securities Institute of Australia).

Mr Breeze has worked on capital raising, structuring and public listing of more than seventy companies involving over $250 million. These capital raisings encompassed a diverse range of fields including gold, food, technology, oil and gas and manufacturing.

At present, Mr Breeze is a director of Molecular Discovery Systems Limited, Asset Energy Pty Ltd, Cortical Dynamics Limited, Diagnostic Array Systems Limited, Onshore Energy Pty Ltd and Advent Energy Limited.

As on 30th June 2019, Mr Breeze held ~311 million BPH shares, representing 10.38 per cent interest in the company.

Tony Huston, Non-Executive Director

Mr Tony (Anthony) Huston, aged 64 years, has been engaged in hydrocarbon and engineering industries for both offshore and onshore development/exploration for more than 35 years. He commenced his early career with Fitzroy Engineering Ltd, majorly working on the advancement of onshore oil fields.

Focusing on shallow pay that had been ignored or passed from prior operations, he formed his own E&P Company in 1996 on re-entry of onshore wells, that turned out to be successful. Later, he opened up two plays 15 years ago, which are still in operation.

In the last ten years, his focus has been on utilising new technology for improved resource recovery, that has been demonstrated in multiple fields, including Italy, the US, Turkmenistan, Oman and Mexico.

As on 30th June 2019, Mr Huston held 20 million BPH shares and 2 million unlisted options.

Charles Maling, Non-Executive Director

Mr Charles Maling, aged 65 years, holds a bachelor’s degree in Sociology and Anthropology with a Media minor. He has worked with the Western Australian (WA) State Government Department of the Environment for fourteen years and further eight years for the Environmental Protection Agency (EPA). He was previously the Communications Officer for the EPA WA office with a responsibility of advising the EPA Chairman on media issues.

He has performed different administrative roles including environmental regulation, environmental research (involving a major study on Western Australian estuaries and Perth Metropolitan coastal waters) and enforcement and media management.

Currently, he is also a Non-Executive Director of Grandbridge. As on 30th June 2019, Mr Charles Maling held 44.5k BPH shares and 2 million unlisted options.

One can note that BPH possesses a highly competent and experienced management team with extensive experience in their respective areas. The company’s robust and sound management team has been a key contributory factor in its accelerated progress.

BPH traded last on 13th November 2019 at $0.001. The stock has generated a six-month return of 50 per cent.


Disclaimer

This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. The above article is sponsored but NOT a solicitation or recommendation to buy, sell or hold the stock of the company (or companies) under discussion. We are neither licensed nor qualified to provide investment advice through this platform.

Checkout our Free Dividend Stocks Report

Specially made for income-hungry investors, Invest in growing Franked Dividends an opportunity that should not be missed.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report